Amgen Inc.

Amgen Inc.

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.
Founded
1985
Raised
$12M
Follow us
Featured on
Pulse 2.0

Senti Biosciences (SNTI) Surged 68.28%: Details You Should Know

MedCity News

AbbVie & Alector drop Alzheimer’s med from alliance, shifting focus to a 2nd drug

Pulse 2.0

Sutro Biopharma (STRO) Stock: Why It Surged Over 19% Today

Pulse 2.0

Kymera Therapeutics (KYMR) Stock Price: Why It Increased Over 3.5% Today

Pulse 2.0

Immatics (IMTX) Stock Price: Why It Increased 3.18% Today

Pulse 2.0

Ardelyx (ARDX) Stock: Why The Price Surged Over 30% Today

Pulse 2.0

Ardelyx (ARDX) Stock: Why The Pricee Jumped Up Today

Pulse 2.0

Ardelyx (ARDX) Stock: Why It Surged Today

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Substantially Fell

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Substantially Fell Today

MedCity News

Aetion acquires Replica Analytics to bring aboard synthetic data capabilities

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Increased Today

MedCity News

BMS joins off the shelf cell therapy chase with alliance on Immatics cancer drug

Pulse 2.0

Ardelyx (ARDX) Stock: $6 Price Target From Ladenburg

Pulse 2.0

Ardelyx (ARDX) Stock: Why The Price Increased

Pulse 2.0

Ardelyx (ARDX): Why The Price Jumped Today

MedCity News

FDA turns down Ardelyx’s chronic kidney disease drug and asks for another trial

AlleyWatch

Aetion Adds Another $19M to its Series B to Make Sense of Drug Development and Treatment Data

$82,000,000 Venture capital (Series B)
MedCity News

Aetion completes $82M Series B round with $19M extension

$40,000,000 Venture capital
FinSMEs

Science 37 Raises $40M in Funding